NEW YORK (dpa-AFX) - The analyst firm Jefferies has left its rating for Evonik at "Hold" with a target price of 20 euros. The midpoint of the new target range for the adjusted operating result (adj. EBITDA) for 2024 is 5 percent above consensus, analyst Chris Counihan wrote on Monday afternoon after the forecast increase. Accordingly, he expects a slightly positive reaction./ag/la/ck
Publication of the original study: 15.07.2024 / 06:45 / ET
First dissemination of the original study: 15.07.2024 / 06:45 / ET
-----------------------
dpa-AFX Broker - the Trader News from dpa-AFX
-----------------------